Jon Blaskovich
Chief Tech/Sci/R&D Officer at BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profile
Mr. Jon Blaskovich is a Director-Information Technology at Biohaven Pharmaceutical Holding Co. Ltd. He received his undergraduate degree from Rochester Institute of Technology.
Jon Blaskovich active positions
| Companies | Position | Start |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | - |
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | - |
Former positions of Jon Blaskovich
| Companies | Position | End |
|---|---|---|
Epsilon Data Management LLC
 Epsilon Data Management LLC Advertising/Marketing ServicesCommercial Services Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX. | Chief Tech/Sci/R&D Officer | - |
Training of Jon Blaskovich
| Rochester Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOHAVEN LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Epsilon Data Management LLC
Epsilon Data Management LLC Advertising/Marketing ServicesCommercial Services Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- Jon Blaskovich
